A18 Cellular signalling of human monocytes in Huntington's disease

Schure, U; Magnusson, A; Lahiri, N; André, R; Rabbanian, S; Lowdell, M W; Bjorkqvist, M; Tabrizi, S J
September 2010
Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA6
Academic Journal
Background In previous work, we described an altered innate immune response in Huntington's disease (HD), demonstrating that proinflammatory cytokines such as interleukin (IL)-6 were significantly increased in the striatum and plasma of HD patients. We also reported altered peripheral and CNS myeloid cell function with elevated IL6 production in mutant htt expressing cells in both HD patients and mouse models of HD, suggesting that altered myeloid cell function may be relevant to HD pathogenesis. Furthermore, alterations in innate immune cell function in the CNS appear to mimic those in the periphery, suggesting that monitoring peripheral myeloid cells may provide insights into the potentially pathogenic actions of myeloid cells in the brain. Aims To analyse expression of other proinflammatory cytokines in mutant htt expressing myeloid cells and to examine signalling pathways involved in their production. Methods Cytokine production was measured using the MesoScale multiplex ELISA platform. NF-κB and JAK-STAT signalling were assessed by specific activity assays and Phospho-Flow FACS analysis, respectively. Results Lipopolysaccharide stimulated monocytes from HD patients showed a significant increase in production of proinflammatory cytokines such as IL6, IL8 and IL1β in symptomatic and pre-manifest HD patients. We then examined activation of the NF-κB and JAK/STAT signalling pathways, demonstrating that symptomatic HD patients showed increased NF-κB activation compared with controls and that basal STAT5 levels appear to increase with disease progression. STAT5 is known to interact with the NF-κB pathway in the production of IL6, and alterations in these pathways could contribute to the increase in proinflammatory cytokines produced by monocytes from HD patients. Conclusions Ongoing work involves the further characterisation of these signalling pathways in myeloid cells in HD. To date, however, our data suggest altered intracellular signalling in HD may underlie the overproduction of proinflammatory cytokines by HD monocytes.


Related Articles

  • HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation. Träger, Ulrike; Andre, Ralph; Lahiri, Nayana; Magnusson-Lind, Anna; Weiss, Andreas; Grueninger, Stephan; McKinnon, Chris; Sirinathsinghji, Eva; Kahlon, Shira; Pfister, Edith L.; Moser, Roger; Hummerich, Holger; Antoniou, Michael; Bates, Gillian P.; Luthi-Carter, Ruth; Lowdell, Mark W.; Björkqvist, Maria; Ostroff, Gary R.; Aronin, Neil; Tabrizi, Sarah J. // Brain: A Journal of Neurology;Mar2014, Vol. 137 Issue 3, p819 

    The peripheral immune response is altered in Huntington’s disease, but the underlying mechanisms are unclear. Using RNA interference to lower huntingtin levels in leucocytes from patients, Träger et al. reverse disease-associated phenotypes including cytokine elevation and...

  • Huntington's Disease.  // World Book Science Dataset;1/1/2009, p1 

    Huntington's Disease

  • Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cells. Terada, Yoshio; Inoshita, Seiji; Nakashima, Osamu; Yamada, Takehisa; Tamamori, Mimi; Ito, Hiroshi; Sasaki, Sei; Marumo, Fumiaki // Kidney International;Jan1998, Vol. 53 Issue 1, p76 

    Examines the role of cyclin D1, p16 and retinoblastoma gene in the regulation of mitogenic signaling of endothelin (ET) in rat mesangial cells. Proliferation of glomerular mesangial cells in glomerular diseases; Protection of ET A-receptor against renal disease progression; Increase of...

  • Genetic discrimination: Huntington's disease and the Americans with Disabilities Act. Gin, Brian R. // Columbia Law Review;Jun97, Vol. 97 Issue 5, p1406 

    Discusses generally the problems of genetic discrimination, and addresses specifically the issue of whether presymptomatic persons who test positive for Huntington's disease are with a `disability' within the meaning of the Americans with Disability Act (ADA). Use of analogy between...

  • Ageing: Proteins clump with age.  // Nature;8/19/2010, Vol. 466 Issue 7309, p904 

    An abstract of the article which states that ageing worms accumulate protein clumps similar to humans with Alzheimer's and Huntington's disease is presented.

  • Functional Phenotype of Synovial Monocytes Modulating Inflammatory T-Cell Responses in Rheumatoid Arthritis (RA). Yoon, Bo Ruem; Yoo, Su-Jin; Choi, Yeon ho; Chung, Yeon-Ho; Kim, Jinhyun; Yoo, In Seol; Kang, Seong Wook; Lee, Won-Woo // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Monocytes function as crucial innate effectors in the pathogenesis of chronic inflammatory diseases, including autoimmunity, as well as in the inflammatory response against infectious pathogens. Human monocytes are heterogeneous and can be classified into three distinct subsets based on CD14 and...

  • Apoptosis : Understanding of the signaling pathways. Sharma M.; Kumar R.; Dhingra R. // International Journal of Biological & Medical Research;May2012, Vol. 3 Issue 3, p2306 

    Apoptosis (programmed cell death) or cell annihilation imparts important role during various normal physiological systems of human body. Moreover, the inappropriate rate of apoptosis has been linked with pathophysiology of various diseases like preeclampsia, alzheimer's disease, huntington's,...

  • Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington’s Disease T Lymphocytes. Miller, James R. C.; Träger, Ulrike; Andre, Ralph; Tabrizi, Sarah J. // PLoS ONE;11/3/2015, Vol. 10 Issue 10, p1 

    Huntington’s disease is a fatal neurodegenerative condition caused by a CAG repeat expansion in the huntingtin gene. The peripheral innate immune system is dysregulated in Huntington’s disease and may contribute to its pathogenesis. However, it is not clear whether or to what...

  • CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Bin-Zhi Qian; Jiufeng Li; Hui Zhang; Kitamura, Takanori; Jinghang Zhang; Campion, Liam R.; Kaiser, Elizabeth A.; Snyder, Linda A.; Pollard, Jeffrey W. // Nature;7/14/2011, Vol. 475 Issue 7355, p222 

    Macrophages, which are abundant in the tumour microenvironment, enhance malignancy. At metastatic sites, a distinct population of metastasis-associated macrophages promotes the extravasation, seeding and persistent growth of tumour cells. Here we define the origin of these macrophages by showing...

  • A Genome-Scale RNA--Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington's Disease. Miller, John P.; Yates, Bridget E.; Al-Ramahi, Ismael; Berman, Ari E.; Sanhueza, Mario; Kim, Eugene; de Haro, Maria; DeGiacomo, Francesco; Torcassi, Cameron; Holcomb, Jennifer; Gafni, Juliette; Mooney, Sean D.; Botas, Juan; Ellerby, Lisa M.; Hughes, Robert E. // PLoS Genetics;Nov2012, Vol. 8 Issue 11, Special section p1 

    A genome-scale RNAi screen was performed in a mammalian cell-based assay to identify modifiers of mutant huntingtin toxicity. Ontology analysis of suppressor data identified processes previously implicated in Huntington's disease, including proteolysis, glutamate excitotoxicity, and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics